The current treatment for corneal opacities associated with conjunctivitis is judicious anti-inflammatory treatment, but the choice of agents is controversial, and outcomes are variable.32 Both host and agent features are potentially important contributors to treatment outcomes, and APOE may play a role in host cornea response and in guiding treatment. This evidence concerns the gene APOE and Corneal opacity.